Spatial and Temporal Patterns of Expression of 11β-Hydroxysteroid Dehydrogenase Types 1 and 2 Messenger RNA and Glucocorticoid Receptor Protein in the Murine Placenta and Uterus During Late Pregnancy1

Abstract To gain insight into the role of 11β-hydroxysteroid dehydrogenase (11β-HSD) enzymes and actions of glucocorticoids in the murine placenta and uterus, the expression pattern of the mRNA for 11β-HSD1 and 11β-HSD2 and the glucocorticoid receptor (GR) protein were determined from Embryonic Day 12.5 (E12.5, term = E19) to E18.5 by in situ hybridization and immunohistochemistry, respectively. Consistent with its putative role in regulating the transplacental passage of maternal glucocorticoid to the fetus, 11β-HSD2 mRNA was highly expressed in the labyrinthine zone (the major site of maternal/fetal exchange) at E12.5, and its level decreased dramatically at E16.5, when it became barely detectable. Remarkably, the silencing of 11β-HSD2 gene expression coincided with the onset of 11β-HSD1 gene expression in the labyrinth at E16.5 when moderate levels of 11β-HSD1 mRNA were detected and maintained to E18.5. By contrast, neither 11β-HSD1 mRNA nor 11β-HSD2 mRNA were detected in any cell types within the basal zone from E12.5 to E18.5. Moreover, the expression of 11β-HSD1 and 11β-HSD2 in the decidua exhibited a high degree of cell specificity in that the mRNA for both 11β-HSD1 and 11β-HSD2 was detected in the decidua-stroma but not in the compact decidua. A distinct pattern was also observed within the endometrium where the mRNA for 11β-HSD1 was expressed in the epithelium, whereas that for 11β-HSD2 was confined strictly to the stroma. By comparison, the expression of GR in the placenta and uterus was ubiquitous and unremarkable throughout late pregnancy. In conclusion, the present study demonstrates for the first time remarkable spatial and temporal patterns of expression of 11β-HSD1 and 11β-HSD2 and GR in the murine placenta and uterus and highlights the intricate control of not only transplacental passage of maternal glucocorticoid to the fetus but also local glucocorticoid action during late pregnancy.

[1]  J. Flier,et al.  A Transgenic Model of Visceral Obesity and the Metabolic Syndrome , 2001, Science.

[2]  M. Kilby,et al.  Reduced placental 11beta-hydroxysteroid dehydrogenase type 2 mRNA levels in human pregnancies complicated by intrauterine growth restriction: an analysis of possible mechanisms. , 2001, The Journal of clinical endocrinology and metabolism.

[3]  M. Venihaki,et al.  Circadian rise in maternal glucocorticoid prevents pulmonary dysplasia in fetal mice with adrenal insufficiency. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[4]  V. Han,et al.  Spatial and temporal patterns of expression of messenger RNA for insulin-like growth factors and their binding proteins in the placenta of man and laboratory animals. , 2000, Placenta.

[5]  J. Cross.  Genetic insights into trophoblast differentiation and placental morphogenesis. , 2000, Seminars in cell & developmental biology.

[6]  C. Edwards,et al.  Hypertension in mice lacking 11beta-hydroxysteroid dehydrogenase type 2. , 1999, The Journal of clinical investigation.

[7]  B. Waddell,et al.  Dual function of 11beta-hydroxysteroid dehydrogenase in placenta: modulating placental glucocorticoid passage and local steroid action. , 1999, Biology of reproduction.

[8]  L. Muglia,et al.  Proliferation and differentiation defects during lung development in corticotropin-releasing hormone-deficient mice. , 1999, American journal of respiratory cell and molecular biology.

[9]  M. Kilby,et al.  11Beta-hydroxysteroid dehydrogenase type 2 in human pregnancy and reduced expression in intrauterine growth restriction. , 1998, Human reproduction.

[10]  R. Benediktsson,et al.  Tissue-Specific Messenger Ribonucleic Acid Expression of 11β-Hydroxysteroid Dehydrogenase Types 1 and 2 and the Glucocorticoid Receptor within Rat Placenta Suggests Exquisite Local Control of Glucocorticoid Action. , 1998, Endocrinology.

[11]  Edwards,et al.  11 b-Hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid-inducible responses and resist hyperglycemia on obesity or stress , 1997 .

[12]  Kaiping Yang,et al.  Placental 11 beta-hydroxysteroid dehydrogenase: barrier to maternal glucocorticoids. , 1997, Reviews of reproduction.

[13]  B. Shin,et al.  Glucose transporter GLUT3 in the rat placental barrier: a possible machinery for the transplacental transfer of glucose. , 1997, Endocrinology.

[14]  T. Mune,et al.  11β-Hydroxysteroid Dehydrogenase and the Syndrome of Apparent Mineralocorticoid Excess , 1997 .

[15]  B. Waddell,et al.  Zonal distribution of 11 beta-hydroxysteroid dehydrogenase types 1 and 2 messenger ribonucleic acid expression in the rat placenta and decidua during late pregnancy. , 1996, Biology of reproduction.

[16]  S. Kitanaka,et al.  Apparent mineralocorticoid excess due to 11β‐hydroxysteroid dehydrogenase deficiency: a possible cause of intrauterine growth retardation , 1996, Clinical endocrinology.

[17]  J. Seckl,et al.  The ontogeny of 11 beta-hydroxysteroid dehydrogenase type 2 and mineralocorticoid receptor gene expression reveal intricate control of glucocorticoid action in development. , 1996, Endocrinology.

[18]  C. Edwards,et al.  11 beta-hydroxysteroid dehydrogenase is an exclusive 11 beta- reductase in primary cultures of rat hepatocytes: effect of physicochemical and hormonal manipulations. , 1995, Endocrinology.

[19]  T. Cole,et al.  Cloning of the mouse 11 beta-hydroxysteroid dehydrogenase type 2 gene: tissue specific expression and localization in distal convoluted tubules and collecting ducts of the kidney. , 1995, Endocrinology.

[20]  A. Aguzzi,et al.  Targeted disruption of the glucocorticoid receptor gene blocks adrenergic chromaffin cell development and severely retards lung maturation. , 1995, Genes & development.

[21]  L. Muglia,et al.  Corticotropin-releasing hormone deficiency reveals major fetal but not adult glucocorticoid need , 1995, Nature.

[22]  C. Edwards,et al.  Cloning, sequencing and tissue-distribution of mouse 11β-hydroxysteroid dehydrogenase-1 cDNA , 1995, The Journal of Steroid Biochemistry and Molecular Biology.

[23]  Z. Krozowski,et al.  Cloning and tissue distribution of the human 1 lβ-hydroxysteroid dehydrogenase type 2 enzyme , 1994, Molecular and Cellular Endocrinology.

[24]  D. Carson,et al.  Regulated expression of prostaglandin endoperoxide synthase-2 by uterine stroma. , 1994, Endocrinology.

[25]  C. Edwards,et al.  'Liver-type' 11 beta-hydroxysteroid dehydrogenase cDNA encodes reductase but not dehydrogenase activity in intact mammalian COS-7 cells. , 1994, Journal of molecular endocrinology.

[26]  P. Stewart,et al.  11 beta-Hydroxysteroid dehydrogenase. , 1994, Vitamins and hormones.

[27]  R. Bigsby,et al.  Progesterone and dexamethasone inhibition of uterine epithelial cell proliferation: Studies with antiprogesterone compounds in the neonatal mouse , 1993, The Journal of Steroid Biochemistry and Molecular Biology.

[28]  R. Benediktsson,et al.  Dysfunction of placental glucocorticoid barrier: link between fetal environment and adult hypertension? , 1993, The Lancet.

[29]  V. Han,et al.  Insulin-like growth factor-II (IGF-II) messenger ribonucleic acid is expressed in steroidogenic cells of the developing ovine adrenal gland: evidence of an autocrine/paracrine role for IGF-II. , 1992, Endocrinology.

[30]  G. Hammond,et al.  Cloning of an ovine 11 beta-hydroxysteroid dehydrogenase complementary deoxyribonucleic acid: tissue and temporal distribution of its messenger ribonucleic acid during fetal and neonatal development. , 1992, Endocrinology.

[31]  E. Albrecht,et al.  Regulation of 1lβ-Hydroxysteroid Dehydrogenase Activity in the Baboon Placenta by Estrogen* , 1990 .

[32]  P. White,et al.  Cloning and expression of rat cDNA encoding corticosteroid 11 beta-dehydrogenase. , 1989, The Journal of biological chemistry.

[33]  E. Albrecht,et al.  Comparison of cortisol-cortisone interconversion in vitro by the human and baboon placenta , 1984, Steroids.

[34]  M. Novy,et al.  Dexamethasone and estradiol treatment in pregnant rhesus macaques: effects on gestational length, maternal plasma hormones, and fetal growth. , 1983, American journal of obstetrics and gynecology.

[35]  K. Taya,et al.  In vivo and in vitro ovarian steroidogenesis in the pregnant rat. , 1981, Biology of reproduction.

[36]  J. Reinisch,et al.  Prenatal exposure to prednisone in humans and animals retards intrauterine growth. , 1979, Science.

[37]  P. Galand,et al.  Effects of cortisol on uterine eosinophilia and other oestrogenic responses , 1975, Molecular and Cellular Endocrinology.

[38]  F. Sullivan,et al.  Plasma corticosterone levels during pregnancy in the mouse: the relative contributions of the adrenal glands and foeto-placental units. , 1974, The Journal of endocrinology.

[39]  A. Burton,et al.  Studies on corticosterone-receptor complexes from mouse placenta. , 1974, Canadian journal of biochemistry.

[40]  R. Benediktsson,et al.  Tissue-specific Messenger Ribonucleic Acid Expression of 11␤-hydroxysteroid Dehydrogenase Types 1 and 2 and the Glucocorticoid Receptor within Rat Placenta Suggests Exquisite Local Control of Glucocorticoid Action* , 2022 .

[41]  J. Challis,et al.  Regulation of 11β-hydroxysteroid dehydrogenase type 1 and 2 by progesterone, estrogen and camp pathway in cultured human placental and chorionic trophoblasts , 1998 .

[42]  E. Albrecht,et al.  Regulation of 11 beta-hydroxysteroid dehydrogenase activity in the baboon placenta by estrogen. , 1990, Endocrinology.

[43]  B. Waddell,et al.  The regulation of transplacental cortisol-cortisone metabolism by estrogen in pregnant baboons. , 1988, Endocrinology.

[44]  R. Roberts,et al.  Disproportionate growth of organs and body weight following glucocorticoid treatment of the rat fetus. , 1982, Developmental Pharmacology and Therapeutics.